HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt
Immunogenetics · 2024-08 · 76 (4) · 243-260
DOI: 10.1007/s00251-024-01343-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunogenetics, online erschienen am 21.06.2024. Verfasst von Yasser ElNahass und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Institute, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Gene Frequency, Haplotypes, Bone Marrow Transplantation, Alleles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
HLA alleles are representative of ethnicities and may play important roles in predisposition to hematological disorders. We analyzed DNA samples for HLA-A, -B, -C, -DRB1, and -DQB1 loci, from 1550 patients and 4450 potential related donors by PCR-SSO (Polymerase chain reaction sequence-specific oligonucleotides) and estimated allele frequencies in donors and patients from 1550 families who underwent bone marrow transplantation (BMT) in Egypt. We also studied the association between HLA allele frequencies and incidence of acute myeloid leukemia, acute lymphoblastic leukemia, and severe aplastic anemia. The most frequently observed HLA class I alleles were HLA- A*01:01 (16.9%), A*02:01 (16.1%), B*41:01 (8.7%), B*49:01 (7.3%), C*06:02 (25.1%), and C*07:01 (25.1%), and the most frequently observed class II alleles were HLA-DRB1*11:01 (11.8%), DRB1*03:01 (11.6%), DQB1*03:01 (27.5%), and DQB1*05:01 (18.9%). The most frequently observed haplotypes were A*33:01~B*14:02 ~ DRB1*01:02 (2.35%) and A*01:01~B*52:01~DRB1*15:01 (2.11%). HLA-DRB1*07:01 was associated with higher AML odds (OR, 1.26; 95% CI, 1.02-1.55; p = 0.030). Only HLA-B38 antigen showed a trend towards increased odds of ALL (OR, 1.52; 95% CI, 1.00-2.30; p = 0.049) HLA-A*02:01, -B*14:02, and -DRB1*15:01 were associated with higher odds of SAA (A*02:01: OR, 1.35; 95% CI, 1.07-1.70; p = 0.010; B*14:02: OR, 1.43; 95% CI, 1.06-1.93; p = 0.020; DRB1*15:01: OR, 1.32; 95% CI, 1.07-1.64; p = 0.011). This study provides estimates of HLA allele and haplotype frequencies and their association with hematological disorders in an Egyptian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Cancer Institute, Cairo University, Cairo, Egypt.
- Nasser Institute, Ministry of Health, Cairo, Egypt.
- Faculty of Science, Cairo University, Cairo, Egypt.
- Nasser Institute, Ministry of Health, Cairo, Egypt. nabil.mahmoud20@pharma.asu.edu.eg.
- Faculty of Medicine, Cairo University, Cairo, Egypt.
- Genome Onco-center, Cairo, Egypt.
ORCID-Profile: Nabil M Abdelfattah
Zitieren
APA
ElNahass, Y., Mekky, N., Abdelfattah, N. M., Abdelfattah, R., Samra, M., Fahmy, O. A., Fathy, G., Elmetnawy, W., Sabet, S., Bassiouny, H., Nader, H., ElHaddad, A., & Mahmoud, H. K. (2024). HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt. Immunogenetics, 76(4), 243-260. https://doi.org/10.1007/s00251-024-01343-x
Vancouver
ElNahass Y, Mekky N, Abdelfattah NM, Abdelfattah R, Samra M, Fahmy OA, et al. HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt. Immunogenetics. 2024;76(4):243-260. doi:10.1007/s00251-024-01343-x
BibTeX
@article{ElNahass2024,
author = {ElNahass, Yasser and Mekky, Nourhan and Abdelfattah, Nabil M and Abdelfattah, Raafat and Samra, Mohamed and Fahmy, Omar A and Fathy, Gamal and Elmetnawy, Wafaa and Sabet, Salwa and Bassiouny, Heba and Nader, Heba and ElHaddad, Alaa and Mahmoud, H K},
title = {HLA alleles, haplotypes frequencies, and their association with hematological disorders: a report from 1550 families whose patients underwent allogeneic bone marrow transplantation in Egypt},
journal = {Immunogenetics},
year = {2024},
volume = {76},
number = {4},
pages = {243--260},
doi = {10.1007/s00251-024-01343-x}
}
EUVIMED